These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8874389)

  • 1. Aberrant expression of a hemidesmosomal protein, bullous pemphigoid antigen 2, in human squamous cell carcinoma.
    Yamada T; Endo R; Tsukagoshi K; Fujita S; Honda K; Kinoshita M; Hasebe T; Hirohashi S
    Lab Invest; 1996 Oct; 75(4):589-600. PubMed ID: 8874389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hemidesmosomal transmembrane collagenous molecule, the 180-kDa bullous pemphigoid antigen (BPA II), is phosphorylated with 12-O-tetradecanoylphorbol-13-acetate in a human squamous cell carcinoma cell line (DJM-1).
    Kitajima Y; Owada MK; Fujisawa Y; Seishima M; Yaoita H; Hirako Y; Owaribe K
    Epithelial Cell Biol; 1995; 4(2):70-5. PubMed ID: 8688920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of collagen XVII expression during transformation of oral epithelium to dysplasia and carcinoma.
    Parikka M; Kainulainen T; Tasanen K; Väänänen A; Bruckner-Tuderman L; Salo T
    J Histochem Cytochem; 2003 Jul; 51(7):921-9. PubMed ID: 12810842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy.
    Stelkovics E; Korom I; Marczinovits I; Molnar J; Rasky K; Raso E; Ficsor L; Molnar B; Kopper L; Krenacs T
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):433-41. PubMed ID: 18633319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester- and calcium-induced reorganization of 180-kDa bullous pemphigoid antigen on the ventral surface of cultured human keratinocytes as studied by immunofluorescence and immunoelectron microscopy.
    Kitajima Y; Owaribe K; Nishizawa Y; Jokura Y; Yaoita H
    Exp Cell Res; 1992 Nov; 203(1):17-24. PubMed ID: 1426040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased mRNA expression of several basement membrane components in basal cell carcinoma.
    Chopra A; Maitra B; Korman NJ
    J Invest Dermatol; 1998 Jan; 110(1):52-6. PubMed ID: 9424087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic growth of squamous cell carcinomas is correlated with upregulation and redistribution of hemidesmosomal components.
    Herold-Mende C; Kartenbeck J; Tomakidi P; Bosch FX
    Cell Tissue Res; 2001 Dec; 306(3):399-408. PubMed ID: 11735040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.
    Westgate GE; Weaver AC; Couchman JR
    J Invest Dermatol; 1985 Mar; 84(3):218-24. PubMed ID: 2579167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization.
    Hopkinson SB; Riddelle KS; Jones JC
    J Invest Dermatol; 1992 Sep; 99(3):264-70. PubMed ID: 1512461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 180-kD bullous pemphigoid antigen/type XVII collagen: tissue-specific expression and molecular interactions with keratin 18.
    Aho S; Uitto J
    J Cell Biochem; 1999 Mar; 72(3):356-67. PubMed ID: 10022517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of monoclonal antibodies against the intracellular domain of hemidesmosomal type XVII collagen.
    Olaru F; Mihai S; Petrescu I; Zillikens D; Sitaru C
    Hybridoma (Larchmt); 2006 Jun; 25(3):158-62. PubMed ID: 16796463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular cleavage of bullous pemphigoid antigen 180/type XVII collagen and its involvement in hemidesmosomal disassembly.
    Hirako Y; Yoshino K; Zillikens D; Owaribe K
    J Biochem; 2003 Feb; 133(2):197-206. PubMed ID: 12761182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
    Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
    Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
    J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interaction between the intracellular domains of bullous pemphigoid antigen 2 (BP180) and beta 4 integrin, hemidesmosomal components of basal keratinocytes.
    Aho S; Uitto J
    Biochem Biophys Res Commun; 1998 Feb; 243(3):694-9. PubMed ID: 9500991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone.
    Li K; Guidice GJ; Tamai K; Do HC; Sawamura D; Diaz LA; Uitto J
    J Invest Dermatol; 1992 Sep; 99(3):258-63. PubMed ID: 1512460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.
    Stanley JR; Tanaka T; Mueller S; Klaus-Kovtun V; Roop D
    J Clin Invest; 1988 Dec; 82(6):1864-70. PubMed ID: 2461961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible cell-biologic mechanism involved in blister formation of bullous pemphigoid: anti-180-kD BPA antibody is an initiator.
    Kitajima Y; Hirako Y; Owaribe K; Yaoita H
    Dermatology; 1994; 189 Suppl 1():46-9. PubMed ID: 8049562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.